Cardiovascular medication use following percutaneous coronary intervention: The Australian experience

Cardiovascular medication use following percutaneous coronary intervention: The Australian experience

Aims: Despite the guidelines, a "treatment gap" exists in the delivery of pharmacotherapy for secondary prevention. We aimed to analyze the trend in guideline-based medication usage following percutaneous coronary intervention (PCI) using the Melbourne Interventional Group (MIG) registry o...

Full description

Bibliographic Details
Main Authors: Cole, J., Brennan, A., Ajani, A., Yan, B., Duffy, S., Loane, P., Reid, Christopher, Yudi, M., New, G., Black, A., Shaw, J., Clark, D., Andrianopoulos, N.
Format: Journal Article
Published: Blackwell Publishing Ltd 2014
Online Access:http://hdl.handle.net/20.500.11937/44961

Internet

http://hdl.handle.net/20.500.11937/44961

Similar Items